
    
      Participants will be given Avastin as well as ABVD (Adriamycin, Bleomycin, Vinblastine and
      Dacarbazine) intravenously on days 1 and 15 of a 28 day cycle. Participants will receive up
      to a total of 6 cycles of therapy.
    
  